45. X. Yang, H. Hong, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley et al.,
cRGD-functionalized, DOX-conjugated, and
64
Cu-labeled superparamagnetic iron oxide
nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32,
4151–4160 (2011)
46. R.T.M. de Rosales, R. Tavaré, R.L. Paul, M. Jauregui-Osoro, A. Protti, A. Glaria et al.,
Synthesis of
64
Cu(II)–Bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: In vivo evaluation as dual-modality PET–MRI agent.
Angew. Chem. Int. Ed. Engl. 50, 5509–5513 (2011)
47. S. Kim, M.K. Chae, M.S. Yim, I.H. Jeong, J. Cho, C. Lee et al., Hybrid PET/MR imaging of
tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 34, 8114–8121 (2013)
48. N.K. Devaraj, E.J. Keliher, G.M. Thurber, M. Nahrendorf, R. Weissleder,
18
F labeled
nanoparticles for in vivo PET-CT imaging. Bioconjug. Chem. 20, 397–401 (2009)
49. E. Boros, A.M. Bowen, L. Josephson, N. Vasdev, J.P. Holland, Chelate-free metal ion
binding and heat-induced radiolabeling of iron oxide nanoparticles. Chem Sci. 6, 225–236
(2015)
50. R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al.,
Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo
dual-modality PET/MR zimaging. Adv. Mater. 26, 5119–5123 (2014)
51. X. Cui, S. Belo, D. Kruger, Y. Yan, R.T.M. de Rosales, M. Jauregui-Osoro et al.,
Aluminium hydroxide stabilised MnFe 2 O 4 and Fe 3 O 4 nanoparticles as dual-modality
contrasts agent for MRI and PET imaging. Biomaterials 35, 5840–5846 (2014)
52. F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis
of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52, 13319–13323 (2013)
53. R.A. Sperling, P. Rivera Gil, F. Zhang, M. Zanella, W.J. Parak, Biological applications of
gold nanoparticles. Chem. Soc. Rev. 37, 1896–1908 (2008)
54. W. Cai, T. Gao, H. Hong, J. Sun, Applications of gold nanoparticles in cancer
nanotechnology. Nanotechnol. Sci. Appl. 1, 17–32 (2008)
55. J. Turkevich, P.C. Stevenson, J. Hillier, A study of the nucleation and growth processes in
the synthesis of colloidal gold. Discuss. Faraday Soc. 11, 55–75 (1951)
56. N. Khlebtsov, L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a
review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647–1671 (2011)
57. D. Goia, E. Matijević, Tailoring the particle size of monodispersed colloidal gold. Colloids
Surf. Physicochem. Eng. Asp. 146, 139–152 (1999)
58. R. Herizchi, E. Abbasi, M. Milani, A. Akbarzadeh, Current methods for synthesis of gold
nanoparticles. Artif. Cells Nanomed. Biotechnol. 44, 596–602 (2016)
59. C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, E.C. Goldsmith et al., Gold
nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721–
1730 (2008)
60. S. Mallidi, T. Larson, J. Aaron, K. Sokolov, S. Emelianov, Molecular specific optoacoustic
imaging with plasmonic nanoparticles. Opt. Express 15, 6583–6588 (2007)
61. J.K. Young, E.R. Figueroa, R.A. Drezek, Tunable nanostructures as photothermal
theranostic agents. Ann. Biomed. Eng. 40, 438–459 (2012)
62. X. Huang, M.A. El-Sayed, Gold nanoparticles: Optical properties and implementations in
cancer diagnosis and photothermal therapy. J. Adv. Res. 1, 13–28 (2010)
63. X. Huang, P.K. Jain, I.H. El-Sayed, M.A. El-Sayed, Plasmonic photothermal therapy
(PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217 (2007)
64. N. Zhao, Y. Pan, Z. Cheng, H. Liu, Gold nanoparticles for cancer theranostics: a brief
update. J. Innov. Opt. Health Sci. 9, 1–10 (2016)
65. M. Das, K.H. Shim, S.S.A. An, D.K. Yi, Review on gold nanoparticles and their
applications. Toxicol. Environ. Health Sci. 3, 193–205 (2011)
66. B.E. Ocampo-García, F.M. de Ramírez, G. Ferro-Flores, L.M. De León-Rodríguez, C.L.
Santos-Cuevas, E. Morales-Avila et al.,
99m
Tc-labeled gold nanoparticles capped with
HYNIC-peptide/mannose for sentinel lymph node detection. Nucl. Med. Biol. 38, 1–11
(2011)
40
C. A. Ferreira et al.
cRGD-functionalized, DOX-conjugated, and
64
Cu-labeled superparamagnetic iron oxide
nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32,
4151–4160 (2011)
46. R.T.M. de Rosales, R. Tavaré, R.L. Paul, M. Jauregui-Osoro, A. Protti, A. Glaria et al.,
Synthesis of
64
Cu(II)–Bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: In vivo evaluation as dual-modality PET–MRI agent.
Angew. Chem. Int. Ed. Engl. 50, 5509–5513 (2011)
47. S. Kim, M.K. Chae, M.S. Yim, I.H. Jeong, J. Cho, C. Lee et al., Hybrid PET/MR imaging of
tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 34, 8114–8121 (2013)
48. N.K. Devaraj, E.J. Keliher, G.M. Thurber, M. Nahrendorf, R. Weissleder,
18
F labeled
nanoparticles for in vivo PET-CT imaging. Bioconjug. Chem. 20, 397–401 (2009)
49. E. Boros, A.M. Bowen, L. Josephson, N. Vasdev, J.P. Holland, Chelate-free metal ion
binding and heat-induced radiolabeling of iron oxide nanoparticles. Chem Sci. 6, 225–236
(2015)
50. R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al.,
Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo
dual-modality PET/MR zimaging. Adv. Mater. 26, 5119–5123 (2014)
51. X. Cui, S. Belo, D. Kruger, Y. Yan, R.T.M. de Rosales, M. Jauregui-Osoro et al.,
Aluminium hydroxide stabilised MnFe 2 O 4 and Fe 3 O 4 nanoparticles as dual-modality
contrasts agent for MRI and PET imaging. Biomaterials 35, 5840–5846 (2014)
52. F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis
of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52, 13319–13323 (2013)
53. R.A. Sperling, P. Rivera Gil, F. Zhang, M. Zanella, W.J. Parak, Biological applications of
gold nanoparticles. Chem. Soc. Rev. 37, 1896–1908 (2008)
54. W. Cai, T. Gao, H. Hong, J. Sun, Applications of gold nanoparticles in cancer
nanotechnology. Nanotechnol. Sci. Appl. 1, 17–32 (2008)
55. J. Turkevich, P.C. Stevenson, J. Hillier, A study of the nucleation and growth processes in
the synthesis of colloidal gold. Discuss. Faraday Soc. 11, 55–75 (1951)
56. N. Khlebtsov, L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a
review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647–1671 (2011)
57. D. Goia, E. Matijević, Tailoring the particle size of monodispersed colloidal gold. Colloids
Surf. Physicochem. Eng. Asp. 146, 139–152 (1999)
58. R. Herizchi, E. Abbasi, M. Milani, A. Akbarzadeh, Current methods for synthesis of gold
nanoparticles. Artif. Cells Nanomed. Biotechnol. 44, 596–602 (2016)
59. C.J. Murphy, A.M. Gole, J.W. Stone, P.N. Sisco, A.M. Alkilany, E.C. Goldsmith et al., Gold
nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721–
1730 (2008)
60. S. Mallidi, T. Larson, J. Aaron, K. Sokolov, S. Emelianov, Molecular specific optoacoustic
imaging with plasmonic nanoparticles. Opt. Express 15, 6583–6588 (2007)
61. J.K. Young, E.R. Figueroa, R.A. Drezek, Tunable nanostructures as photothermal
theranostic agents. Ann. Biomed. Eng. 40, 438–459 (2012)
62. X. Huang, M.A. El-Sayed, Gold nanoparticles: Optical properties and implementations in
cancer diagnosis and photothermal therapy. J. Adv. Res. 1, 13–28 (2010)
63. X. Huang, P.K. Jain, I.H. El-Sayed, M.A. El-Sayed, Plasmonic photothermal therapy
(PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217 (2007)
64. N. Zhao, Y. Pan, Z. Cheng, H. Liu, Gold nanoparticles for cancer theranostics: a brief
update. J. Innov. Opt. Health Sci. 9, 1–10 (2016)
65. M. Das, K.H. Shim, S.S.A. An, D.K. Yi, Review on gold nanoparticles and their
applications. Toxicol. Environ. Health Sci. 3, 193–205 (2011)
66. B.E. Ocampo-García, F.M. de Ramírez, G. Ferro-Flores, L.M. De León-Rodríguez, C.L.
Santos-Cuevas, E. Morales-Avila et al.,
99m
Tc-labeled gold nanoparticles capped with
HYNIC-peptide/mannose for sentinel lymph node detection. Nucl. Med. Biol. 38, 1–11
(2011)
40
C. A. Ferreira et al.